$13.89
-0.110 (-0.786%)
At Close: Jul 31, 2026
Bayer's sNDA for Kerendia Label Expansion Gets FDA's Priority Review
01:55pm, Tuesday, 18'th Mar 2025
The FDA accepts and grants priority review to BAYRY's sNDA for Kerendia to treat patients with a common form of heart failure.
Bayer welcomes new law in U.S. state to better shield it against glyphosate litigation
06:27am, Monday, 17'th Mar 2025
Bayer said on Monday that it welcomed a new law about to be passed in the U.S. state of Georgia to better protect the maker of crop protection chemicals against glyphosate litigation.
Bayer wins Brazil injunction in soy patent row with farmers
12:18pm, Friday, 14'th Mar 2025
Germany's Bayer has won an injunction to suspend a court ruling that gave Brazilian soybean farmers the right to reimbursement for royalties paid for expired patents of genetically modified soy seeds,
Exclusive: Bayer share drop draws market regulator's scrutiny, source says
11:25am, Tuesday, 11'th Mar 2025
Germany's financial markets watchdog has started an initial probe to examine whether Bayer fairly disclosed plans to get shareholder approval for a potential capital increase, a regulatory source told
Bayer told analysts of cash call plan a day before official statement
03:59pm, Friday, 07'th Mar 2025
Bayer told several brokerages about plans to seek shareholder permission to issue shares one day before formally announcing the news on Friday, which weighed heavily on the stock, analysts' notes seen
Is Bayer (BAYRY) Outperforming Other Medical Stocks This Year?
10:40am, Friday, 07'th Mar 2025
Here is how Bayer Aktiengesellschaft (BAYRY) and AbbVie (ABBV) have performed compared to their sector so far this year.
Bayer warns US lawmakers it may halt Roundup sales without stronger legal protections: report
09:47am, Friday, 07'th Mar 2025
Bayer AG (ETR:BAYN, OTC:BAYZF) has told US lawmakers it may halt sales of its popular Roundup weedkiller in the United States unless stronger legal protections are implemented to protect the company
Bayer seeks investor approval for 35% cash call to gird for litigation
06:43am, Friday, 07'th Mar 2025
Bayer said on Friday it would seek shareholder approval to raise fresh equity capital worth close to 35% of its currently outstanding shares over the next three years to be ready for any U.S. litigati
Bayer eyes exit from popular Roundup amid US legal risks
01:49am, Friday, 07'th Mar 2025
Bayer has warned U.S. lawmakers it could stop selling the popular Roundup weedkiller if they cannot provide better legal protection against product liability litigation, according to a financial analy
Bayer Q4 Earnings In Line, Revenues Top on Nubeqa, Kerendia Sales
04:00pm, Wednesday, 05'th Mar 2025
BAYRY's fourth-quarter earnings match expectations. Revenues top estimates, driven by the strong performance of its pharmaceutical business.
Bayer Aktiengesellschaft (BAYZF) Q4 2024 Earnings Call Transcript
01:32pm, Wednesday, 05'th Mar 2025
Bayer Aktiengesellschaft (OTCPK:BAYZF) Q4 2024 Earnings Conference Call March 5, 2025 8:00 AM ET Company Participants Jost Reinhard - IR Bill Anderson - Chairman & CEO Wolfgang Nickl - CFO Rodrigo San
Bayer CEO: 2025 Will Be 'Most Difficult' Year In Turnaround Plan, Expects Improved Performance From 2026 Onwards
11:52am, Wednesday, 05'th Mar 2025
On Wednesday, Bayer AG BAYRY reported fourth-quarter 2024 adjusted EPS of $0.28, missing the consensus of $1.00.
Bayer sees improvement in 2026 after profit decline this year
01:43am, Wednesday, 05'th Mar 2025
Bayer on Wednesday raised the prospect of a return to earnings growth next year after reiterating that a decline was expected for this year.
Bayer faces investors' impatience ahead of fourth-quarter results
08:28am, Tuesday, 04'th Mar 2025
Bayer's CEO is facing increasing investor pressure to deliver on turnaround efforts and reverse a forecast earnings decline this year, as the group prepares to release quarterly results on Wednesday.
February is American Heart Month - Expert with Bayer Discusses Key Risk Factors for Heart Disease and Shares Practical Tips for Improving Heart Health
Sign In
Buy BAYRY